Lansforsakringar Fondforvaltning AB (publ)

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 2059323 Stockholm, V7

Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,443,442

-$1,500,118 QoQ

Shares Held

11,892

-11.2% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#221

of 870 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Lansforsakringar Fondforvaltning AB (publ) holds $29,337,552 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	134,828	$9,688,740
2	TEVA	Teva Pharmaceutical Industries Ltd	256,489	$8,689,847
3	UTHR	UNITED THERAPEUTICS Corp This page	11,892	$6,443,442
4	NBIX	Neurocrine Biosciences Inc	26,792	$4,515,523

All Filings in UTHR

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,443,442	11,892	-11.2%	Shares	Sole	2026-08-13
2026-03-31	$7,943,560	13,396	+0.3%	Shares	Sole	2026-04-23
2025-12-31	$6,508,198	13,357	+1.3%	Shares	Sole	2026-02-12
2025-09-30	$5,526,445	13,183	+0.2%	Shares	Sole	2025-11-10
2025-06-30	$3,779,801	13,154	-2.9%	Shares	Sole	2025-08-13
2025-03-31	$4,174,284	13,541	0.0%	Shares	Sole	2025-05-14
2024-12-31	$4,777,806	13,541	—	Shares	Sole	2025-03-14
No filing history on record for this holder in this stock.